Mieville, V.; Gubala, J.; Fiault, M.; Ota, M.; Han, S.; Urwyler, M.; Benamran, D.; Tille, J.-C.; Valerio, M.; Nowak-Sliwinska, P.
Rational Design of Non-Toxic Multidrug Combinations Demonstrates Durable and Hypoxia-Enhanced Efficacy Against Renal Cell Carcinoma. Pharmaceutics 2025, 17, 1269.
https://doi.org/10.3390/pharmaceutics17101269
AMA Style
Mieville V, Gubala J, Fiault M, Ota M, Han S, Urwyler M, Benamran D, Tille J-C, Valerio M, Nowak-Sliwinska P.
Rational Design of Non-Toxic Multidrug Combinations Demonstrates Durable and Hypoxia-Enhanced Efficacy Against Renal Cell Carcinoma. Pharmaceutics. 2025; 17(10):1269.
https://doi.org/10.3390/pharmaceutics17101269
Chicago/Turabian Style
Mieville, Valentin, Jakub Gubala, Mathis Fiault, Marie Ota, Seungsu Han, Muriel Urwyler, Daniel Benamran, Jean-Christophe Tille, Massimo Valerio, and Patrycja Nowak-Sliwinska.
2025. "Rational Design of Non-Toxic Multidrug Combinations Demonstrates Durable and Hypoxia-Enhanced Efficacy Against Renal Cell Carcinoma" Pharmaceutics 17, no. 10: 1269.
https://doi.org/10.3390/pharmaceutics17101269
APA Style
Mieville, V., Gubala, J., Fiault, M., Ota, M., Han, S., Urwyler, M., Benamran, D., Tille, J.-C., Valerio, M., & Nowak-Sliwinska, P.
(2025). Rational Design of Non-Toxic Multidrug Combinations Demonstrates Durable and Hypoxia-Enhanced Efficacy Against Renal Cell Carcinoma. Pharmaceutics, 17(10), 1269.
https://doi.org/10.3390/pharmaceutics17101269
